A detailed history of Cito Capital Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cito Capital Group, LLC holds 7,550 shares of AMGN stock, worth $2.1 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
7,550
Previous 8,550 11.7%
Holding current value
$2.1 Million
Previous $2.67 Million 8.91%
% of portfolio
0.91%
Previous 1.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $309,380 - $337,380
-1,000 Reduced 11.7%
7,550 $2.43 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $284,245 - $352,898
1,300 Added 17.93%
8,550 $2.3 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $219,270 - $242,570
-1,000 Reduced 12.12%
7,250 $1.75 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $546,720 - $725,100
-3,000 Reduced 26.67%
8,250 $1.67 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $1.88 Million - $2.15 Million
11,250
11,250 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cito Capital Group, LLC Portfolio

Follow Cito Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.